1511 / 1631
Breast Implant–Associated Anaplastic Large-Cell Lymphoma
(retrospective analysis 87 patients)
Results
•
Median follow-up time: 45 months (range, 3 to 217 months).
•
Median OS time after diagnosis of BI-ALCL:13 years
•
OS rate: 93% and 89% at 3 and 5 years, respectively
•
Significantly EFS and OS in patients with:
–
lymphoma confined by the fibrous capsule surrounding the
implant (vs lymphoma that had spread beyond the capsule )
–
a complete surgical excision that consisted of total capsulectomy
with breast implant removal compared (vs partial capsulectomy,
systemic chemotherapy, or radiation therapy)
Clemens et al., JCO 2016